Skip to main content
Oncology Learning Network Live Daily

ASH 2026 Morning Livestream, Day 1

Thank you for visiting. On-demand content is coming soon.

Experts discuss the evolving role of CAR T therapy, T-cell engagers, and antibody-drug conjugates in multiple myeloma. The panel also highlights key headline data across hematologic malignancies.

© 2026 HMP Global. All Rights Reserved.  

Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Oncology Learning Network or HMP Global, their employees, and affiliates.